174 related articles for article (PubMed ID: 25332254)
1. Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
Ramsey SD; Henry NL; Gralow JR; Mirick DK; Barlow W; Etzioni R; Mummy D; Thariani R; Veenstra DL
J Clin Oncol; 2015 Jan; 33(2):149-55. PubMed ID: 25332254
[TBL] [Abstract][Full Text] [Related]
2. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
3. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
4. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
Accordino MK; Wright JD; Vasan S; Neugut AI; Hillyer GC; Hu JC; Hershman DL
J Clin Oncol; 2016 Aug; 34(24):2820-6. PubMed ID: 27161970
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
7. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
Ramsey SD; Fedorenko C; Chauhan R; McGee R; Lyman GH; Kreizenbeck K; Bansal A
J Oncol Pract; 2015 Jul; 11(4):338-43. PubMed ID: 26060225
[TBL] [Abstract][Full Text] [Related]
8. Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harm.
Jochelson M; Hayes DF; Ganz PA
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714444
[TBL] [Abstract][Full Text] [Related]
9. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
10. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
[TBL] [Abstract][Full Text] [Related]
11. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
Stokes ME; Thompson D; Montoya EL; Weinstein MC; Winer EP; Earle CC
Value Health; 2008; 11(2):213-20. PubMed ID: 18380633
[TBL] [Abstract][Full Text] [Related]
12. Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
Neuman HB; Schumacher JR; Schneider DF; Winslow ER; Busch RA; Tucholka JL; Smith MA; Greenberg CC
Ann Surg Oncol; 2017 Mar; 24(3):683-691. PubMed ID: 27709403
[TBL] [Abstract][Full Text] [Related]
13. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
14. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
15. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
Sail KR; Franzini L; Lairson DR; Du XL
Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974
[TBL] [Abstract][Full Text] [Related]
17. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
18. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.
Dinan MA; Wilson LE; Reed SD
J Natl Compr Canc Netw; 2019 Mar; 17(3):245-254. PubMed ID: 30865923
[TBL] [Abstract][Full Text] [Related]
20. Surveillance mammography for Medicaid/Medicare breast cancer patients.
Carcaise-Edinboro P; Bradley CJ; Dahman B
J Cancer Surviv; 2010 Mar; 4(1):59-66. PubMed ID: 20091247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
